Skip to main content
. 2014 Aug 29;9(8):e105792. doi: 10.1371/journal.pone.0105792

Figure 5. Growth inhibitory effects of combined drug treatments in MCF-7, T47D, SKBr3 and MDA-MB-231 cell lines.

Figure 5

Cells were treated with trametinib in association with everolimus, NVP-BEZ235 or GSK2126458 for 3 days with [3H]-thymidine added for the last 6 hours. Results were shown as the mean ± standard error from duplicate experiments.